Due to a number of factors, including economic challenges including persistently high interest rates and the residual effects ...
A type of risky debt that has taken US capital markets by storm in the past year is now emerging in bonds designed to unlock ...
Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results